Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 56.12%5.69B | 5.90%20.55B | 12.83%14.32B | 16.54%10.17B | 29.73%3.64B | 20.17%19.4B | 29.83%12.69B | 45.91%8.73B | 47.82%2.81B | 26.19%16.15B |
| Operating income | 56.12%5.69B | 5.90%20.55B | 12.83%14.32B | 16.54%10.17B | 29.73%3.64B | 20.17%19.4B | 29.83%12.69B | 45.91%8.73B | 47.82%2.81B | 26.19%16.15B |
| Operating expenses | -60.00%-5.2B | -3.25%-18.48B | -9.54%-12.69B | -14.09%-9.22B | -26.27%-3.25B | -18.01%-17.9B | -26.61%-11.58B | -43.20%-8.08B | -42.60%-2.57B | -27.26%-15.17B |
| Gross profit | 24.24%490.13M | 37.37%2.07B | 47.45%1.63B | 47.09%954.22M | 67.50%394.5M | 53.57%1.51B | 77.06%1.1B | 90.86%648.72M | 146.15%235.52M | 11.62%980.27M |
| Selling expenses | -10.83%-6.57M | -73.17%-84.06M | -91.99%-76.28M | 5.71%-12.17M | -14.87%-5.93M | -62.86%-48.54M | -96.31%-39.73M | -1.81%-12.91M | 30.70%-5.16M | 72.60%-29.81M |
| Administrative expenses | -25.81%-176.63M | -18.01%-782.68M | -15.90%-491.43M | -6.51%-309.54M | -4.47%-140.39M | 0.01%-663.2M | 4.78%-424.01M | -6.13%-290.62M | -9.43%-134.38M | -21.12%-663.3M |
| Research and development expenses | 10.83%-176.3M | -1.67%-903.31M | -10.30%-766.06M | -29.94%-549.66M | -44.33%-197.7M | -34.92%-888.46M | -67.49%-694.51M | -82.78%-423.01M | -125.18%-136.98M | -14.28%-658.53M |
| Profit from asset sales | ---- | 99.23%-224.55K | 99.06%-267.5K | 99.42%-187.69K | ---- | -157.93%-29.17M | -160.29%-28.47M | ---32.49M | ---- | 2,743.73%50.35M |
| Revaluation surplus | 233.73%16.71M | 144.48%43.92M | 115.72%13.8M | 114.29%9.27M | 53.72%-12.5M | 3.85%-98.73M | 13.42%-87.78M | -50.01%-64.86M | -732.96%-27.01M | -339.43%-102.69M |
| -Changes in the fair value of other assets | 233.73%16.71M | 144.48%43.92M | 115.72%13.8M | 114.29%9.27M | 53.72%-12.5M | 3.85%-98.73M | 13.42%-87.78M | -50.01%-64.86M | -732.96%-27.01M | -339.43%-102.69M |
| Impairment and provision | -7.84%-2.49M | -361.79%-295.52M | -1,865.13%-220.89M | -913.25%-37.48M | 61.38%-2.31M | -2,182.66%-64M | -210.65%-11.24M | 66.32%-3.7M | 27.98%-5.98M | 97.26%-2.8M |
| -Other impairment is provision | -7.84%-2.49M | -361.79%-295.52M | -1,865.13%-220.89M | -913.25%-37.48M | 61.38%-2.31M | -2,182.66%-64M | -210.65%-11.24M | 66.32%-3.7M | 27.98%-5.98M | 97.26%-2.8M |
| Special items of operating profit | 125.44%345.61M | 133.35%1.01B | 184.68%646.8M | 178.83%504.57M | 650.49%153.3M | 146.84%431.15M | 223.10%227.2M | 595.59%180.96M | 322.49%20.43M | -76.65%174.67M |
| Operating profit | 160.53%476.92M | 793.85%978.71M | 2,847.82%686.52M | 5,817.95%535.27M | 419.63%183.06M | 139.29%109.49M | 109.03%23.29M | 95.64%-9.36M | 40.62%-57.27M | -213.55%-278.69M |
| Financing income | -9.78%64.23M | -0.21%359.37M | -3.63%260.87M | 7.29%196.34M | -23.52%71.2M | -5.94%360.12M | -1.91%270.71M | -9.76%183M | -3.29%93.09M | -13.39%382.84M |
| Financing cost | 22.14%-23.71M | 1.31%-112.26M | -4.14%-86.34M | -12.95%-60.46M | -11.59%-30.45M | 0.87%-113.75M | 4.44%-82.91M | 10.86%-53.53M | 23.34%-27.29M | 25.04%-114.75M |
| Special items of earning before tax | -139.58%-713.41K | 140.64%6.86M | 145.79%2M | 432.35%1.74M | 3,032.24%1.8M | -2.73%2.85M | -61.42%815.33K | -38.05%326.52K | -76.41%57.54K | -44.69%2.93M |
| Earning before tax | 111.38%472.73M | 200.92%1.18B | 308.67%823.67M | 335.31%656.11M | 729.05%223.64M | 437.93%393.2M | 706.17%201.55M | 1,021.80%150.72M | 143.41%26.98M | -89.56%73.09M |
| After-tax profit from continuing operations | 113.84%472.46M | 141.82%1.14B | 192.63%732.23M | 225.90%601.71M | 795.24%220.94M | 542.95%470.69M | 632.52%250.23M | 914.10%184.63M | 147.32%24.68M | -89.69%73.21M |
| Earning after tax | 113.84%472.46M | 141.82%1.14B | 192.63%732.23M | 225.90%601.71M | 795.24%220.94M | 542.95%470.69M | 632.52%250.23M | 914.10%184.63M | 147.32%24.68M | -89.69%73.21M |
| Minority profit | 109.20%76.31M | 39.12%129.98M | 22.46%77.11M | 99.36%75.32M | 291.99%36.48M | 271.63%93.43M | 532.15%62.97M | 581.88%37.78M | 136.52%9.31M | 15.71%25.14M |
| Profit attributable to shareholders | 114.76%396.16M | 167.26%1.01B | 249.84%655.12M | 258.46%526.39M | 1,099.85%184.46M | 684.86%377.26M | 673.83%187.26M | 1,059.43%146.85M | 157.65%15.37M | -93.02%48.07M |
| Basic earnings per share | 114.79%0.2803 | 167.25%0.7133 | 249.81%0.4635 | 258.42%0.3724 | 1,097.25%0.1305 | 685.00%0.2669 | 674.85%0.1325 | 1,054.44%0.1039 | 157.67%0.0109 | -93.02%0.034 |
| Diluted earnings per share | 114.79%0.2803 | 167.25%0.7133 | 249.81%0.4635 | 258.42%0.3724 | 1,097.25%0.1305 | 685.00%0.2669 | 674.85%0.1325 | 1,054.44%0.1039 | 157.67%0.0109 | -93.02%0.034 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | ShinWing Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.